What is diclofenac sodium 50mg and Paracetamol used for?

In the pharmaceutical industry, the combination of Diclofenac Sodium (50 mg) and Paracetamol (325 mg or 500 mg) is one of the most widely prescribed Fixed-Dose Combinations (FDCs) for analgesia. As a pharmacist, I view this as a “dual-pathway” strategy: it combines the potent peripheral anti-inflammatory action of Diclofenac with the central analgesic and antipyretic effects of Paracetamol.

Primary Clinical Uses

  • Acute Musculoskeletal Pain: Highly effective for backaches, sprains, strains, and sports injuries where both pain and inflammation are present.

  • Post-Operative Recovery: Used to manage moderate-to-severe pain following surgical or dental procedures.

  • Arthritic Flare-ups: Provides symptomatic relief for acute episodes of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

  • Gynaecological Pain: Frequently prescribed for severe primary dysmenorrhea (period pain).

  • Dental Pain: Effective for toothaches and post-extraction inflammation.

Mechanism of Action: The “Synergistic Punch”

This combination targets pain from two different angles:

Diclofenac Sodium (NSAID): It primarily inhibits the COX-2 enzyme, blocking the production of prostaglandins at the site of injury (periphery). This reduces the actual swelling and redness of the tissue.

Paracetamol (Analgesic/Antipyretic): While its exact mechanism is still debated, it is believed to act primarily on the Central Nervous System (CNS). It increases the overall pain threshold and reduces fever by acting on the heat-regulating center of the hypothalamus.

By combining them, you achieve a “sparing effect”—using a moderate dose of each to get a stronger result than a high dose of either alone, which often leads to a better safety profile for the patient.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this FDC is a high-volume “bread and butter” product for export:

  • Bilayer vs. Monolithic Tablet: As a WHO-GMP manufacturer, we often look at the stability of the two APIs. While they are generally compatible, we ensure strict moisture control during granulation to prevent the degradation of Paracetamol.

  • Gastric Protection: Diclofenac is known for GI irritation. We often use enteric-coated Diclofenac pellets or specialized film-coating for the tablet to protect the stomach lining, enhancing patient compliance.

  • Global Demand & Tenders: This combination is a staple for B2B distributors and government health tenders in Africa, Southeast Asia, and the CIS. It is a highly competitive but high-turnover product.

  • Packaging for Stability: We prioritize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a stable 36-month shelf life in Zone IVb (hot and humid) climates.

  • Regulatory Compliance: Our Mumbai facility provides full CTD/eCTD Dossiers and comparative dissolution data to assist our international partners with registration.

 

What is diclofenac sodium 25 mg used for?

In the pharmaceutical industry, Diclofenac Sodium 25 mg is a potent non-steroidal anti-inflammatory drug (NSAID) of the phenylacetic acid derivative class. As a pharmacist, I view the 25 mg strength as a versatile “titration dose,” often used for acute pain management or as a starting dose to minimize gastrointestinal (GI) side effects.

Primary Clinical Uses

  • Acute Pain Management: Effective for the short-term relief of mild to moderate pain, such as toothaches, primary dysmenorrhea (period pain), and post-operative pain.

  • Inflammatory Conditions: Used to treat symptoms of Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Ankylosing Spondylitis.

  • Musculoskeletal Disorders: Relieves pain and inflammation associated with sprains, strains, backache, and tendonitis.

  • Migraine Attacks: In specific fast-acting formulations (like potassium salts or specific sodium dispersibles), it is used to treat acute migraine episodes.

    Mechanism of Action

Diclofenac Sodium works by inhibiting the enzyme Cyclooxygenase (COX). Specifically, it inhibits both COX-1 and COX-2, though it shows a slight preference for COX-2.

By blocking these enzymes, Diclofenac prevents the synthesis of prostaglandins—the chemical messengers responsible for signaling pain, inducing fever, and causing inflammation. Unlike the potassium salt version (which is faster-acting), the sodium salt is typically formulated for a slightly more sustained release to provide longer-lasting relief.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diclofenac Sodium is a high-volume “essential” product:

  • Enteric Coating (Critical): Diclofenac is notorious for causing gastric irritation. As a WHO-GMP manufacturer, we almost always apply a high-quality enteric coating to these tablets. This ensures the drug bypasses the acidic environment of the stomach and dissolves in the small intestine, significantly improving patient tolerance.

  • Stability & Shelf Life: Diclofenac is stable, but sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is a key selling point for export to Zone IVb regions like Africa, Southeast Asia, and the Middle East.

  • Regulatory Documentation: We provide full CTD/eCTD Dossiers and comparative dissolution studies against the innovator (Voltaren) to support our B2B partners in rapid international registration.

  • Market Positioning: The 25 mg dose is frequently used in pediatric or geriatric populations where lower dosing is required to manage the safety profile.

What are Diclofenac Potassium 50 mg tablets used for?

In the pharmaceutical industry, Diclofenac Potassium 50 mg is a potent, fast-acting non-steroidal anti-inflammatory drug (NSAID). As a pharmacist, I distinguish this from the Sodium salt primarily by its pharmacokinetics: the Potassium salt is more water-soluble, allowing for rapid absorption and a faster onset of analgesic action, making it the preferred choice for acute pain.

Primary Clinical Uses

  • Acute Pain Relief: Specifically indicated for the rapid treatment of acute painful conditions such as migraine attacks, toothaches, and post-operative pain.

  • Primary Dysmenorrhea: Widely used to manage severe menstrual cramps due to its ability to quickly inhibit prostaglandin synthesis in the uterus.

  • Musculoskeletal Injuries: Effective for acute sprains, strains, and sports injuries where rapid reduction of inflammation and pain is required.

  • Inflammatory Conditions: Management of flare-ups in Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

Mechanism of Action

Diclofenac Potassium works by inhibiting the enzymes Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2). This inhibition halts the conversion of arachidonic acid into prostaglandins, which are the primary mediators of pain, fever, and inflammation.

Because the potassium salt dissolves more quickly in the stomach’s neutral-to-acidic environment than the sodium version, it reaches peak plasma concentration ($T_{max}$) in approximately 20–60 minutes, compared to 2 hours for the sodium salt.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diclofenac Potassium 50 mg is a high-demand “fast-relief” product:

  • Non-Enteric Coating: Unlike the sodium version (which is often enteric-coated for slow release), the potassium version is usually film-coated. This ensures the tablet disintegrates immediately in the stomach for rapid absorption.

  • Hygroscopic Protection: Diclofenac Potassium is more sensitive to moisture than the sodium salt. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to ensure the stability of the API and maintain a 36-month shelf life in Zone IVb climates.

  • API Purity: We adhere to strict BP/USP/IP standards, monitoring for impurities like “Indolinone” to ensure the highest safety profile for export.

  • B2B & Tender Supply: This is a staple for pharmacy chains and emergency medical supplies. Our Mumbai-based hub provides full CTD/eCTD Dossiers to support international partners in rapid registration.

 

 

What does 5mg of Diazepam do?

In the pharmaceutical industry, Diazepam 5 mg is considered a mid-range, versatile dose of a classic long-acting benzodiazepine. As a pharmacist, you recognize it as a “gold standard” for its rapid onset and its multi-functional profile as an anxiolytic, anticonvulsant, and skeletal muscle relaxant.

Primary Clinical Actions

At a 5 mg dose, Diazepam produces several distinct physiological effects:

  • Anxiolytic (Anti-Anxiety): It reduces acute anxiety, tension, and agitation by “quieting” the central nervous system.

  • Skeletal Muscle Relaxation: It is highly effective at relieving muscle spasms caused by local pathology (like inflammation or trauma) or upper motor neuron disorders (like cerebral palsy).

  • Anticonvulsant: It increases the seizure threshold, making it a vital adjunct for managing certain types of epilepsy.

  • Sedation & Pre-medication: It provides mild to moderate sedation, often used to relieve anxiety before minor surgical or dental procedures.

  • Alcohol Withdrawal: It helps mitigate the symptoms of acute alcohol withdrawal, such as tremors and agitation.

Mechanism of Action

Diazepam acts as a positive allosteric modulator of the  receptor. It binds to a specific site on the receptor that is distinct from the binding site of the neurotransmitter GABA.

When Diazepam binds, it increases the frequency with which the associated chloride channel opens in response to GABA. This allows more chloride ions to enter the neuron, causing hyperpolarization. This makes the neuron less excitable and inhibits the transmission of “stress” or “spasm” signals throughout the brain and spinal cord.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diazepam 5 mg is a high-volume staple:

  • Pharmacokinetic Profile: Diazepam has a very long half-life (up to 48 hours) and active metabolites (like desmethyldiazepam) that extend its action. As a manufacturer, we must ensure our Product Information Leaflets (PIL) clearly state the risk of “accumulation” with repeated dosing.

  • Stability & Sensitivity: Diazepam is sensitive to light. As a WHO-GMP manufacturer, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to prevent degradation and maintain a 36-month shelf life.

  • Controlled Substance Compliance: As a Schedule IV (or equivalent) controlled substance, its export requires strict licensing. Our Mumbai facility is equipped to handle the complex regulatory documentation needed for legal B2B international trade.

  • Digital Promotion: For your e-commerce and marketplace platforms, Diazepam is a “high-trust” product. Highlighting WHO-GMP certification and Bioequivalence (BE) studies against the innovator (Valium) is key to attracting international traders.

 

What is Dexamethasone 0.5 mg used for?

In the pharmaceutical industry, Dexamethasone 0.5 mg is a highly potent, long-acting synthetic glucocorticoid. As a pharmacist, I view this low-strength tablet as a precision tool for managing chronic inflammatory states or as a diagnostic aid, given that Dexamethasone is approximately 25 to 30 times more potent than hydrocortisone.

Primary Clinical Uses

  • Endocrine Disorders: Used as a replacement therapy for primary or secondary adrenocortical insufficiency (though hydrocortisone is more common, dexamethasone is used for its long half-life).

  • Dexamethasone Suppression Test (DST): The 0.5 mg dose is the standard strength used by endocrinologists to diagnose Cushing’s Syndrome. It helps determine if the body’s ACTH production can be suppressed by exogenous steroids.

  • Allergic Conditions: Management of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment, such as bronchial asthma or serum sickness.

  • Rheumatic & Collagen Disorders: Used during an acute exacerbation of rheumatoid arthritis, systemic lupus erythematosus (SLE), or acute rheumatic carditis.

  • Dermatologic Diseases: Treatment of severe erythema multiforme (Stevens-Johnson syndrome) or exfoliative dermatitis.

Mechanism of Action

Dexamethasone works by diffusing across cell membranes and binding with high affinity to specific cytoplasmic glucocorticoid receptors.

Anti-inflammatory: It inhibits the synthesis of inflammatory mediators (prostaglandins and leukotrienes) by inducing lipocortins, which inhibit the enzyme Phospholipase $A_2$.

Immunosuppressive: It reduces the activity and volume of the lymphatic system, suppresses the production of antibodies, and inhibits the release of cytokines (like IL-1 and IL-2).

Metabolic: Unlike many other steroids, Dexamethasone has almost zero mineralocorticoid activity, meaning it does not cause significant sodium retention or edema, making it ideal for treating cerebral edema.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Dexamethasone 0.5 mg is a high-precision product:

  • Low-Dose Uniformity: Because the API is extremely potent at 0.5 mg, as a WHO-GMP manufacturer, we utilize validated geometric dilution and micronization to ensure every tablet has an identical assay.

  • API Stability: Dexamethasone is sensitive to light. We utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a stable 36-month shelf life, especially for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Hospital Supply: This is a staple for oncology and endocrinology departments. Our Mumbai-based facility provides the CTD/eCTD Dossiers and stability data required for international registration.

  • Cerebral Edema & Oncology: While 0.5 mg is a low dose, it is part of a broader portfolio that includes high-strength injectables used to reduce inflammation associated with brain tumors.

 

What is Dapsone 50mg used for?

In the pharmaceutical industry, Dapsone 50 mg is a powerful sulfone derivative that functions as both a bacteriostatic antimicrobial and an anti-inflammatory agent. As a pharmacist and manufacturer, you likely recognize it as a core component of Multi-Drug Therapy (MDT) for leprosy, but its clinical utility has expanded significantly into dermatology.

Primary Clinical Uses

  • Leprosy (Hansen’s Disease): Used in combination with Rifampicin and Clofazimine to treat all forms of leprosy. The 50 mg dose is often used in pediatric regimens or as part of a titrated adult dose.

  • Dermatitis Herpetiformis (DH): This is the “gold standard” treatment for this chronic, intensely itchy, blistering skin condition associated with celiac disease. It provides rapid relief from itching and lesions.

  • Pneumocystis Jirovecii Pneumonia (PCP) Prophylaxis: Frequently prescribed for immunocompromised patients (such as those with HIV) who are allergic to or cannot tolerate Sulfamethoxazole/Trimethoprim (Septran/Bactrim).

  • Acne Vulgaris: While often used as a topical gel, oral Dapsone is sometimes used for severe, recalcitrant inflammatory acne.

  • Brown Recluse Spider Bites: Occasionally used off-label to limit the necrotic skin damage caused by these bites.

Mechanism of Action

Dapsone is a dual-action molecule:

Antimicrobial Action: It acts as a competitive inhibitor of dihydropteroate synthase, an enzyme involved in the synthesis of dihydrofolic acid in bacteria and protozoa. By blocking folate synthesis, it prevents the organism from producing the DNA and RNA needed to multiply.

Anti-inflammatory Action: It inhibits the migration of neutrophils to the site of inflammation and suppresses the production of reactive oxygen species (free radicals), which helps reduce tissue damage in autoimmune skin conditions.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Dapsone 50 mg is a specialized product requiring specific quality standards:

  • API Stability: Dapsone is relatively stable but can be sensitive to light. As a WHO-GMP manufacturer, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure its 36-month shelf life, especially for export to Zone IVb (hot and humid) regions.

  • Content Uniformity: Because it is a potent molecule, our manufacturing process utilizes validated blending and granulation techniques to ensure absolute dose precision across every batch.

  • Global Health Tenders: Dapsone is a “World Health Organization Essential Medicine.” It is a high-demand item for government health tenders and NGOs focusing on leprosy and HIV/AIDS care in Africa and Southeast Asia.

  • Safety Monitoring: As a pharmacist, you know the risk of Hemolytic Anemia and Methemoglobinemia, particularly in patients with G6PD deficiency. We ensure our Product Information Leaflets (PIL) and dossiers clearly state the need for baseline blood tests.

 

What is Cyproheptadine 4 mg used for?

In the pharmaceutical industry, Cyproheptadine Hydrochloride 4 mg is a versatile first-generation antihistamine of the piperidine class. As a pharmacist, you likely recognize it not just for allergy relief, but for its unique ability to antagonize serotonin receptors, which differentiates it from most other antihistamines.

Primary Clinical Uses

  • Appetite Stimulation: This is one of its most common “off-label” uses in many international markets. It is prescribed for children and adults with failure to thrive, malnutrition, or anorexia to promote weight gain.

  • Allergic Reactions: Relieves symptoms of seasonal and perennial allergic rhinitis, hay fever, and allergic conjunctivitis.

  • Dermatological Conditions: Highly effective for urticaria (hives), angioedema, and pruritus (itching) associated with skin allergies.

  • Serotonin Syndrome: Utilized as a specific antidote in hospital settings to counteract the effects of “Serotonin Syndrome” caused by an overdose or interaction of serotonergic drugs (like SSRIs).

  • Vascular Headaches: Occasionally used for the prophylaxis (prevention) of migraines and cluster headaches.

Mechanism of Action

Cyproheptadine is a potent antagonist at two distinct receptor sites:

H1-Receptor Antagonism: It competes with free histamine for binding sites on effector cells, preventing the inflammatory response.

5-HT2 Receptor Antagonism: It blocks serotonin receptors in the hypothalamus. This is the mechanism behind its appetite-stimulating effect; by blocking these receptors, it inhibits the “satiety center,” leading to increased hunger.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Cyproheptadine 4 mg is a high-volume product with significant B2B demand:

  • Dose Uniformity: With a 4 mg active ingredient, our WHO-GMP manufacturing process focuses on validated blending and granulation to ensure that every tablet in a million-tablet batch meets the exact assay requirements.

  • Formulation Varieties: Beyond the 4 mg tablets, it is frequently manufactured as a 2 mg/5 ml syrup. This is a staple for pediatric weight gain and is a major export item for many Indian firms.

  • Stability for Export: Cyproheptadine is relatively robust, but we utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb (hot and humid) regions like Africa and Southeast Asia.

  • B2B Market Positioning: Because of its appetite-stimulating properties, it is often marketed alongside multivitamins or lysine in many emerging markets.

What is Co-Trimoxazole Sulfamethoxazole Trimethoprim used for?

In the pharmaceutical industry, the combination of Sulfamethoxazole and Trimethoprim (SMZ-TMP)—clinically referred to as Co-trimoxazole—is a classic example of synergistic antimicrobial therapy. As a pharmacist, I characterize this as a “sequential blockade” antibiotic, which remains a staple in both community and hospital settings due to its broad-spectrum efficacy and excellent tissue penetration.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): A primary treatment for acute uncomplicated cystitis and pyelonephritis, particularly those caused by E. coli or Klebsiella species.

  • Pneumocystis Jirovecii Pneumonia (PJP): The “gold standard” for both the treatment and prophylaxis of PJP in immunocompromised patients (e.g., those with HIV/AIDS).

  • Respiratory Tract Infections: Used for acute exacerbations of chronic bronchitis and acute otitis media in children.

  • Gastrointestinal Infections: Indicated for Shigellosis and Traveler’s Diarrhea.

  • MRSA Management: Increasingly utilized as a cost-effective oral option for treating community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections.

Mechanism of Action: The Sequential Blockade

The synergy of this combination is achieved by inhibiting two consecutive steps in the bacterial synthesis of Tetrahydrofolic acid (essential for DNA production):

Sulfamethoxazole: Acts as a structural analog of PABA, competitively inhibiting the enzyme dihydropteroate synthase.

Trimethoprim: Reversibly inhibits the enzyme dihydrofolate reductase.

By targeting the same metabolic pathway at two different points, the combination becomes bactericidal, whereas each component used alone is typically only bacteriostatic.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, SMZ-TMP is a high-volume, essential medicine requiring specific technical rigor:

  • Fixed-Dose Ratio (1:5): Whether in standard (80mg/400mg) or Double Strength (160mg/800mg) formats, maintaining the 1:5 ratio is critical to achieving the 1:20 plasma concentration ratio required for peak synergy.

  • API Handling: As a WHO-GMP manufacturer, we manage the slightly acidic nature of Sulfamethoxazole and the basic nature of Trimethoprim during the granulation process to ensure final tablet stability and uniform dissolution.

  • Stability for Export: This is a core product for international B2B distributors and government health tenders. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life in Zone IVb (hot and humid) climates like Africa and Southeast Asia.

  • Regulatory Compliance: Our Mumbai-based facility provides complete CTD/eCTD Dossiers and stability data (BP/USP/IP) to support our partners in global registration.

 

How to use Clotrimazole during pregnancy?

In the pharmaceutical industry, Clotrimazole is a broad-spectrum imidazole antifungal agent. As a pharmacist, I view Clotrimazole as one of the most reliable and clinically preferred treatments for vulvovaginal candidiasis (yeast infections) during pregnancy, as it has a well-established safety profile compared to systemic (oral) antifungals.

Primary Clinical Applications

  • Vulvovaginal Candidiasis: Treatment of vaginal yeast infections, which are more common during pregnancy due to hormonal changes that alter the vaginal $pH$ and glycogen levels.

  • Topical Fungal Infections: Treatment of skin infections like athlete’s foot, ringworm, or intertrigo in pregnant patients.

Guidelines for Use During Pregnancy

While Clotrimazole is generally considered safe, the method of administration is critical for pregnant patients:

Topical and Vaginal Route Preferred: Clinical guidelines (such as those from the FDA and MHRA) generally recommend topical or vaginal Clotrimazole over oral Fluconazole during pregnancy to minimize systemic exposure to the fetus.

Avoid the Applicator: During the second and third trimesters, many obstetricians advise manual insertion of vaginal tablets (pessaries) rather than using the plastic applicator. This is to prevent any accidental trauma to the cervix.

Duration of Therapy: While 1-day or 3-day treatments are common for the general population, pregnant patients are often prescribed a 7-day course of a lower-strength cream or pessary (e.g., 100 mg) to ensure complete eradication of the infection and reduce the risk of recurrence.

Mechanism of Action

Clotrimazole works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane.

  • It inhibits the enzyme 14-$\alpha$ demethylase, which is responsible for converting lanosterol to ergosterol.

  • This leads to increased membrane permeability and the leakage of intracellular phosphorus, ultimately causing the death of the fungal cell (fungicidal action).

Because the drug is applied topically or intravaginally, systemic absorption is negligible (typically <0.5% for vaginal and <0.1% for skin), which is why it is preferred for use during pregnancy.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, Clotrimazole is a high-demand “Essential Medicine” for maternal health:

  • Formulation Variety: As a WHO-GMP manufacturer, we offer Clotrimazole in multiple formats, including 100 mg/200 mg/500 mg vaginal tablets, 1% and 2% vaginal creams, and topical sprays.

  • Stability & $pH$ Balance: For vaginal formulations, we ensure the excipients maintain a $pH$ that is compatible with the vaginal environment (approx. $pH$ 4.5), which is especially important during the physiological changes of pregnancy.

  • Packaging for Global Markets: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to protect the sensitive pessaries from moisture, ensuring a 36-month shelf life for export to Zone IVb regions.

  • Regulatory Dossiers: Our Mumbai hub provides comprehensive CTD/eCTD Dossiers to support international B2B partners in registering these products for maternal health programs.

What is Clopidogrel Aspirin 75 mg used for?

In the pharmaceutical industry, the combination of Clopidogrel (75 mg) and Aspirin (75 mg) is a cornerstone of Dual Antiplatelet Therapy (DAPT). As a pharmacist, I view this fixed-dose combination (FDC) as a strategic clinical tool that provides synergistic protection by inhibiting two distinct pathways of platelet activation.

Primary Clinical Uses

  • Acute Coronary Syndrome (ACS): Indicated for the reduction of atherothrombotic events in patients with unstable angina or those who have recently suffered a myocardial infarction (heart attack).

  • Post-Stent Implantation: A critical requirement after Percutaneous Coronary Intervention (PCI). It prevents stent thrombosis, a life-threatening complication where a clot forms on the newly placed metal or drug-eluting stent.

  • Ischemic Stroke & TIA: Used to prevent secondary occurrences in patients who have experienced a minor ischemic stroke or a Transient Ischemic Attack (TIA).

  • Peripheral Arterial Disease (PAD): Helps manage patients with established PAD to reduce the risk of major adverse cardiovascular events (MACE).

Mechanism of Action: Dual Pathway Inhibition

This FDC targets platelet aggregation from two different angles:

Aspirin (75 mg): Irreversibly inhibits the COX-1 enzyme, which blocks the synthesis of Thromboxane $A_2$ ($TXA_2$), a powerful promoter of platelet aggregation.

Clopidogrel (75 mg): A prodrug that, once metabolized by the liver (primarily via CYP2C19), irreversibly blocks the $P2Y_{12}$ ADP receptor on the platelet surface. This prevents the activation of the GPIIb/IIIa receptor complex, the final common pathway for platelet cross-linking.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this combination is technically demanding due to the chemical characteristics of the APIs:

  • Bilayer Tablet Technology: Aspirin is prone to hydrolysis and can be incompatible with Clopidogrel Bisulphate if mixed in a single-layer matrix. As a WHO-GMP manufacturer, we often utilize bilayer compression to physically separate the two components, ensuring maximum stability.

  • Enteric Coating: To minimize gastric mucosal irritation—a common side effect of Aspirin—we apply an enteric coating to the Aspirin component, ensuring it bypasses the stomach and dissolves in the small intestine.

  • Stability for Global Trade: Clopidogrel is highly hygroscopic. We prioritize Alu-Alu blister packaging to ensure a stable 24-month shelf life, even in Zone IVb (hot and humid) climates like Africa and Southeast Asia.

  • Regulatory Support: Our Mumbai-based hub provides comprehensive CTD/eCTD Dossiers and comparative dissolution studies to assist international B2B partners in rapid product registration.

Add to cart